Investors are evaluating argenx's recent performance amid questions of valuation.
argenx NV ADR's stock has come under scrutiny following a report suggesting that it may be fully priced after a remarkable 185% increase. As of the latest close, the stock is trading at US$817.16, reflecting a 1.54% decline on the day and an 11.02% drop over the past week. The stock has also decreased by 17.48% over the past month and is down 3.30% year-to-date.
Investor takeaway: Investors should closely monitor the company's upcoming developments and market reactions.
Advertisement
argenx NV ADR
ARGX.US
ARGX.US
argenx NV ADR
WealthAwesomeMarket cap
$51.88B
P/E
31.4x
52W high
$1072.75
52W low
$661.85
1W change
-11.02%
Beta
-0.04
Analyst Price Targets
Based on 25 analysts covering ARGX · as of Oct 12, 2026
Wall Street analysts forecast ARGX stock price to rise 42.1% over the next 12 months.
Consensus
Buy4.48 / 5.00
Avg. Target
C$1154.43
+42.1% Upside
Previously C$1180.26 on Oct 5, 2026
Current Price
C$812.30
Last close
Analyst Breakdown (25 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ARGX's historical volatility
30-Day Vol
41.5%
Annualized
90-Day Vol
47.6%
Annualized
Trend (90d)
-24.2%
Annualized drift
90d Mean
C$744.95
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$789.20 | C$683.98 – C$910.61 |
| 60 trading days | C$766.76 | C$626.28 – C$938.74 |
| 90 trading days | C$744.95 | C$581.42 – C$954.48 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Last Close at US$817.16, Down 1.54%
With a 50-day moving average of US$956.34, the stock is trading 14.6% below this metric.
Bull case
The company has demonstrated strong fundamentals, boasting a profit margin of 32.3% and a substantial market capitalization.
Bear case
The recent decline in the stock price and concerns about being fully priced raise questions about its future performance.
Stock Performance Overview
Advertisement
The report indicating that argenx's stock may be fully priced follows a significant 185% increase. The stock closed at US$817.16, down 1.54% from the previous day. Over the past week, the stock has faced an 11.02% decline, contributing to a 1-month decrease of 17.48%. Year-to-date, the stock is down 3.30%, raising concerns among investors about its current valuation after such a substantial run.
Volume and Market Metrics
Trading volume for argenx was reported at 3,813 shares, which is notably below the 20-day average volume of 405,372 shares, indicating reduced trading activity. The stock is currently positioned within a 52-week range of US$661.85 to US$1072.75, suggesting it is trading at approximately 38% of its range. The stock's P/E ratio stands at 31.44, with a market cap of approximately US$51.88 billion, reflecting its significant valuation within the healthcare sector.
Future Considerations
Looking ahead, investors will be monitoring argenx's upcoming announcements and clinical trial results, particularly following the mixed news from recent studies. Analysts maintain an average target price of US$1154.43, implying a potential upside of 41.3% from the last closing price. However, the recent price action may prompt investors to reassess their positions in light of the stock's performance against its fundamentals, particularly given its 50-day moving average of US$956.34.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
